Literature DB >> 9104939

Loss of heterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma.

M P Vargas1, Z Zhuang, C Wang, A Vortmeyer, W M Linehan, M J Merino.   

Abstract

Pheochromocytomas and extra-adrenal paragangliomas are tumors of the paraganglia with similar histological characteristics. We examined 12 sporadic pheochromocytomas and 5 extra-adrenal paragangliomas for loss of heterozygosity (LOH) in chromosomes 1p and 3p using a microdissection technique. Chromosomes 1p34-36, 3p21 and the von Hippel-Lindau (VHL) gene locus (3p25) were analyzed. LOH of a selected region on chromosome 1p was detected in 5 of 11 (45%) informative pheochromocytoma cases and in 0 of 5 (0%) informative extra-adrenal paraganglioma cases. LOH of the chromosome 3p25 VHL gene locus was detected in 5 of 9 (45%) informative pheochromocytoma cases and in 0 of 3 (0%) informative extra-adrenal paraganglioma cases. LOH of 3p21 was detected in 2 of 4 (50%) informative extra-adrenal paraganglioma cases. The allelic deletions in chromosomes 1p and 3p appear to be separate events. In conclusion, significant deletions were found at 1p34-36 and 3p25 in sporadic pheochromocytomas but not in extra-adrenal paragangliomas. These findings suggest (1) that multiple genetic factors may be involved in pheochromocytoma tumorigenesis, and (2) extra-adrenal paragangliomas may have a different genetic mechanism of tumorigenesis compared with pheochromocytomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9104939     DOI: 10.1016/s0046-8177(97)90028-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.

Authors:  H Dannenberg; E J Speel; J Zhao; P Saremaslani; E van Der Harst; J Roth; P U Heitz; H J Bonjer; W N Dinjens; W J Mooi; P Komminoth; R R de Krijger
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.

Authors:  Mingjian James You; Diego H Castrillon; Boris C Bastian; Rónán C O'Hagan; Marcus W Bosenberg; Ramon Parsons; Lynda Chin; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 3.  Monosomy 1p36.

Authors:  A Slavotinek; L G Shaffer; S K Shapira
Journal:  J Med Genet       Date:  1999-09       Impact factor: 6.318

4.  Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.

Authors:  E Edström; E Mahlamäki; B Nord; M Kjellman; R Karhu; A Höög; N Goncharov; B T Teh; M Bäckdahl; C Larsson
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 5.  Rethinking pheochromocytomas and paragangliomas from a genomic perspective.

Authors:  L J Castro-Vega; C Lepoutre-Lussey; A-P Gimenez-Roqueplo; J Favier
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

Review 6.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

7.  Evaluation of Endocrine Neoplasms Using Fine Needle Aspiration Biopsy.

Authors:  Mary E. Barcus; Celeste N. Powers
Journal:  Endocr Pathol       Date:  2000       Impact factor: 4.056

8.  Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival.

Authors:  G Ragnarsson; G Eiriksdottir; J T Johannsdottir; J G Jonasson; V Egilsson; S Ingvarsson
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

9.  Clonality Studies in the Analysis of Adrenal Medullary Proliferations: Application Principles and Limitations.

Authors:  Salvador J. Diaz-Cano
Journal:  Endocr Pathol       Date:  1998       Impact factor: 4.056

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.